Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination therapy of a HIF-2-α inhibitor and an immunotherapeutic agent and uses thereof

Combination therapy of a HIF-2-α inhibitor and an immunotherapeutic agent and uses thereof

US Patent 10786480 · Granted Sep 29, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Aryl ethers and uses thereof2024
Aryl ethers and uses thereof2024
Quinazoline analogs as receptor tyrosine kinase inhibitors2021
Aromatic compounds and uses thereof2020
Aromatic compounds and uses thereof2020
Aryl ethers and uses thereof2020
Aryl ethers and uses thereof2020
Compositions for use in treating glioblastoma2019
Combination therapy of a HIF-2-alpha inhibitor and an immunotherapeutic agent an2019
Combination therapy of a HIF-2-alpha inhibitor and an immunotherapeutic agent an2019
Combination therapy of a HIF-2-alpha inhibitor and an immunotherapeutic agent an2019
Compositions for use in treating pulmonary arterial hypertension2019